Alternatively, the efficacy of M-ILP may be boosted by anti-PD-1/PD-L1 treatment based on our results showing induction of PD-L1 on melphalan-exposed melanoma cells and induction of Tregs expressing high levels of PD-1. The gene discussed is CD274; the disease is melanoma.